6-K ·Filed Jul 22, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001575872-26-000518
Actionable Insight • Neutral

Wait for readable filings or news from the company to assess any material events. The pair of 6-Ks filed on the same day with multiple exhibits suggests potential disclosures, but without legible content no trading action is justified.

DirectionNeutral
Confidencelow
Horizonimmediate
Latest settled — T+20d ⚠ clustered
RDY ▲ +6.41% at T+20d
NEUTRAL call ✓ call won +6.41% · α vs SPY +3.52% · entry $11.38 → $12.11
Next anchor: T+60d in 13d
Latest observation: T+49 +26.63% FF3 residual α
Entry anchored
Jul 21, 03:59 PM ET
via exchange tick
T+1d
+3.69%
call +3.69% · α +4.93%
$11.80
settled 2mo ago
T+5d
+3.34%
call +3.34% · α +5.74%
$11.76
settled 2mo ago
T+20d
+6.41%
call +6.41% · α +3.52%
$12.11
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

Two 6-K filings from Dr. Reddy's Laboratories filed on July 22, 2026, each contain exhibits (PDF, HTML, and graphics) whose content is unavailable for analysis due to encoding/truncation. Analysis based on filing metadata only — no material financial or corporate events can be identified from the unreadable documents.

Key Facts

  • Two 6-K filings (Form 6-K) filed on same day (2026-07-22) by Dr. Reddy's Laboratories
  • Exhibits include a PDF (EX-99.1) in first 6-K and an HTML + three JPG graphics in second 6-K
  • Document content is unreadable in the provided text — no financial figures or material disclosures can be extracted
  • Prior filing context: annual 20-F filed 54 days ago was neutral with no material changes

Financial Impact

Cannot be determined — filing content unavailable

Risk Factors

  • Unknown content risk: exhibits may contain material information that could move the stock
  • Low confidence due to unreadable filing text

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (RDY) — Batch item 10001575872-26-000518
Document: 0001575872-26-000518-index.html0001575872-26-000516
Document: 0001575872-26-000518.txt0001575872-26-000518
6-K Filing (RDY) — Batch item 40001575872-26-000516
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access